Predictive value of immune‐inflammation indices in metabolic response and outcome after curative radiotherapy in patients with non‐small cell lung cancer
Author:
Affiliation:
1. Department of Radiation Oncology Suleyman Demirel University Isparta Turkey
2. Department of Nuclear Medicine Suleyman Demirel University Isparta Turkey
Publisher
Wiley
Subject
Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/crj.13217
Reference34 articles.
1. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
3. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
4. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non–Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies
5. Chemoradiotherapy of locally advanced nonsmall cell lung cancer
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy;Scientific Reports;2024-05-25
2. Prediction of severe radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma using the combined systemic immune-inflammatory index and prognostic nutritional index;European Archives of Oto-Rhino-Laryngology;2024-03-12
3. Development and validation of a prognostic nomogram model in locally advanced NSCLC based on metabolic features of PET/CT and hematological inflammatory indicators;EJNMMI Physics;2024-03-05
4. The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy;Cancers;2023-09-11
5. Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence;Annals of Medicine;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3